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Abstract
Background: We developed a personalised antimicrobial information module co-designed with patients. This study
aimed to evaluate the potential impact of this patient-centred intervention on short-term knowledge and understanding
of antimicrobial therapy in secondary care.
Methods: Thirty previous patients who had received antibiotics in hospital within 12 months were recruited to co-design
an intervention to promote patient engagement with infection management. Two workshops, containing five
focus-groups were held. These were audio-recorded. Data were analysed using a thematic framework developed
deductively based on previous work. Line-by-line coding was performed with new themes added to the framework by
two researchers. This was used to inform the development of a patient information module, embedded within an
electronic decision support tool (CDSS).
The intervention was piloted over a four-week period at Imperial College Healthcare NHS Trust on 30 in-patients. Pre- and
post-intervention questionnaires were developed and implemented to assess short term changes in patient knowledge
and understanding and provide feedback on the intervention. Data were analysed using SPSS and NVIVO software.
Results: Within the workshops, there was consistency in identified themes. The participants agreed upon and
co-designed a personalised PDF document that could be integrated into an electronic CDSS to be used by healthcare
professionals at the point-of-care. Their aim for the tool was to provide individualised practical information, signpost to
reputable information sources, and enhance communication between patients and healthcare professionals.
Eighteen out of thirty in-patients consented to participant in the pilot evaluation with 15/18(83%) completing the study.
Median (range) age was 66(22–85) years. The majority were male (10/15;66%). Pre-intervention, patients reported desiring
further information regarding their infections and antibiotic therapy, including side effects of treatment. Deployment of
the intervention improved short term knowledge and understanding of individuals infections and antibiotic management
with median (IQR) scores improving from 3(2–5)/13 to 10(6–11)/13. 13/15(87%) reported that they would use the
intervention again.
(Continued on next page)
* Correspondence: tmr07@ic.ac.uk
1National Institute for Health Research Health Protection Research Unit in
Healthcare Associated Infections and Antimicrobial Resistance, Imperial
College London, Hammersmith Campus, Du Cane Road, London W12 0NN,
UK
2Imperial College Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rawson et al. Antimicrobial Resistance and Infection Control  (2018) 7:43 
https://doi.org/10.1186/s13756-018-0333-1
(Continued from previous page)
Conclusion: A personalised, patient-centred intervention improved understanding and short-term knowledge of
infections and antibiotic therapy in participating patients’. Long term impact on attitudes and behaviours post
discharge will be further investigated.
Keywords: Patient & Public Involvement, Co-design, Antimicrobial prescribing, Shared-decision making
Background
Patient-centred interventions are important for ensuring
appropriate, effective, safe, and responsive provision of
healthcare [1]. When considering antibiotic prescribing and
drug-resistant infections, the role of engaging patients and
sharing in decision making around antibiotic prescribing
can reduce the use of antibiotics in primary care [2]. In
secondary care, there remains a paucity of data to guide
development of patient-centred interventions that support
patient engagement in the decision making process for
antibiotic prescribing and infection management.
The management of acute infection in secondary care
is often seen as a discrete episode. Recent evidence has
demonstrated that poor communication and information
provision during these episodes can have a cumulative
effect on future attitudes and behaviours of patients
towards infections and antibiotic use [3]. To investigate
this, we worked with patients who had received antibiotics
in hospital to co-design a patient-centred intervention.
This intervention would aim to promote better com-
munication and information provision during admission
to hospital about an individual’s infection and antibiotic
therapy.
This study was developed as part of a wider project
aiming to develop and integrate several patient- and
prescriber-focused interventions to support antibiotic
decision making during infection management. This project
is an integrated electronic clinical decision support tool
entitled Enhanced, Personalised, Integrated Care for
Infection Management at the Point-of-Care (EPIC IMPOC).
This tool integrates the ability to interface with data from
patient electronic health records, data visualisation, and a
range of machine learning tools to support individualised
antibiotic selection during infection management [4–6].
However, there is also a need to explore promoting more
holistic approaches to evidence based antibiotic prescribing
within decision support tools [7]. This includes the integra-
tion of patient-facing tools that can help to promote
better understanding about an individual’s infection
and its management [3, 7]. Through integration of these
different modules, our aim is to improve patient engage-
ment with the decision making process. Thus ensuring
that patient views and preferences can be taken into ac-
count and that future attitudes and behaviours towards
antimicrobials become more appropriate [3].
We report the development and pilot evaluation of a
patient-centred intervention, co-designed with patients
and embedded within EPIC IMPOC, to improve patient
knowledge and understanding about the management of




Figure 1 summarises the process of intervention devel-
opment employed within this study. In total, 30 previous
patients who had received antibiotics in hospital during
the preceding 12 months (recruited through Cherry
Picked, UK – a specialist qualitative recruitment company)
participated in two separate 1-h workshops. The first of
these was held in September 2015 and the second in May
2016. Participants were recruited from a sample of 500
people whose data were held within a database of 20,000
individuals from around the UK who had signed up with
the recruitment agency previously. An initial email was
sent to all individuals in the database advertising the
workshops. Respondents were then stratified according
to recruitment criteria and 30 individuals selected for
inclusion (10 were selected for the first workshop and
20 for the second). The primary participant recruitment
criteria for inclusion was that the patient had received
antibiotics in hospital within the preceding 12 months.
We also aimed to select an equal spread of age ranges
(18–24; 25–49; 50–65; 65+), gender, and ethnicities for
the workshops. Following the initial invitation email, two
further emails were sent to these individuals confirming
their participation.
The first workshop, containing two focus groups,
aimed to explore and co-design an outline of the inter-
vention. This workshops outline criteria were based on
the findings of a previously published study exploring
current failures in communication and information
provision around antibiotic prescribing and infection
management in secondary care [3]. The second work-
shop contained a different group of participants and
involved three focus groups. This aimed to triangulate
the findings from the initial workshop and refine the
design of the intervention that had been outlined by the
participants at the first workshop. The number of groups
per workshop (i.e. two and three groups, respectively)
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were selected to optimise the number of individuals
within the focus groups and facilitate triangulation within
workshops. Within workshops, the objectives of the
different focus groups were identical.
Both workshops were facilitated by researchers trained
in qualitative methodology (TMR, LSPM, EC) who
used a standardised topic guide to explore and develop
the intervention in focus groups of 5–7 participants
(Additional files 1 & 2). Participants were consented
and the workshops were audio-recorded. Anonymous
recordings were transcribed verbatim for analysis.
Independent researchers (ECS & BH) acted as observers
for each focus group providing written observations to
allow for greater reflexivity during data analysis.
Data were analysed using NVIVO Pro 11.0 software.
For data analysis, a thematic framework was developed
based on the findings of a previous study [3]. One
researcher (TMR) initially reviewed all transcripts and
data generated during the workshops. Line-by-line coding
was then performed by two independent researchers
(TMR & LSPM) with new emerging themes added to the
framework in an inductive fashion [8]. During line-by-line
coding the comments provided by the observers were
reviewed as well as any written information produced by
the groups during the workshop [9, 10]. This was consid-
ered to help balance areas of reflexivity derived from the
coders’ own background, experiences, and beliefs [11].
After comparing coded transcripts at each interval of
development, a list of categories were generated and
members of the research team met to agree on key
categories and themes that would inform the iterative
design and refinement of the intervention. The interven-
tion is described below in detail, but briefly, took the form
of a personalised PDF document embedded within the
electronic clinical decision support system, EPIC IMPOC.
This allowed automated generation of PDF leaflets
containing patient specific information on their antibiotic
and infection management.
Pilot study
Following workshops 1 and 2, the co-designed interven-
tion was piloted in Imperial College Healthcare NHS
Trust (ICHNT). This pilot aimed to provide an initial
evaluation of the potential impact of the intervention
and ascertain patient feedback on further improvements
required before larger studies could be undertaken. The
pilot involved a pre- and post-intervention questionnaire
delivered 12–24 h either side of the intervention. This
was developed based on the research groups previous
experience of evaluating patient knowledge and under-
standing surrounding antimicrobial therapy and antimicro-
bial resistance [3, 12, 13]. The questionnaires were then
piloted on two healthcare professionals, two members of
the public, and a member of the research department not
involved with this study.
Delivery of the intervention and questionnaires was
facilitated by two members of the research team (TMR
and VA). Participants were purposefully identified by
clinical members of staff for inclusion from separate
clinical wards across three university teaching hospitals
making up ICHNT. These wards were staffed by a range of
specialties (infectious diseases, care of the elderly, respira-
tory, gastroenterology, haematology, nephrology, general
surgery, urology, and orthopaedics).
Over a four-week period, between 7th August and 1st
September 2017, 30 in-patients were invited to participate
in the intervention. Consent was obtained from patients
who agreed to participate by members of the research
team; they remained enrolled in the study for 3 days. After
obtaining consent, participants were asked to complete a
Fig. 1 Summary of intervention development and pilot testing
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15-point questionnaire on day one (Additional file 3).
On day two a member of the research team, following a
pre-determined script designed to simulate a discussion
on infections / antibiotic prescribing during a ward
round or brief clinical consultation (lasting less than
5 min), delivered the intervention. On day three, the
participants were asked to complete a 20-point ques-
tionnaire (Additional file 3). The questionnaires were
designed by the research team and were piloted on two
healthcare professionals, four citizens not associated
with the research team, and a medical student. The study
was designed to assess (i) any short-term improvements in
patient knowledge and understanding of their infection
and antibiotics; (ii) what information was still being
missed during the intervention; and (iii) evaluate the
acceptability and agreement of patients with the interven-
tion. Where answers were marked as correct/incorrect,
members of the research team met and agreed upon
correct responses for the individual participant before
deployment of the questionnaire. Free text answers
were collected and independently analysed inductively by
two members of the research team (TMR and LSPM).
Data were anonymously collected and analysed using
SPSS 24.0 and NVIVO pro 11.0 software. Local regional




There was consistency in identified themes across both
workshops. Participants agreed upon the development of a
personalised PDF document that could be generated using
electronically available data specific to the individual. Par-
ticipants reported that the PDF was the optimal approach
as it allowed the maximum flexibility to either be printed
and given to a patient at the bedside or transferred elec-
tronically. Other approaches considered included the
development of a mobile application, text message services,
and written summaries. The ability to be able to print the
PDF was considered by participants to address some of the
reported concerns about transferring confidential patient
information electronically and would also be available for
patients without access to electronic devices.
“Couldn’t you have an interactive PDF so people can
choose whether or not to include a list of side effects or
just the link for further information?” (Female 1,
workshop 1)
“I like the idea of getting it electronically and
downloading PDFs or something, but I would say an
app’s just getting a little bit to gimmicky” (Male 1,
workshop 2)
“I feel like that a lot of people prefer forms as they can
physically keep track of them [patient information]. I
feel more in control of them then. If you are
comfortable online then it is good, however with
medical records I mean they are quite sensitive, so it
might be nice to have them just in their paper form.”
(Male 2, workshop 1)
Participants reported that the intervention could act as
an important tool for promoting better communication
about infections and antibiotic management between
patients and healthcare professionals. In particular,
participants reported that this may act as a prompt for
further questions and support reflection on their infection
and its management after the consultation has taken
place.
“I usually get home and think ‘oh wait’ I had a really
important question which I forgot to ask. I like to be
able to process things and then kind of gather my
thoughts and find out what I want to know about the
issue.” (Male 3, workshop 1)
Table 1 summarises the key themes that emerged from
the workshops for the content and structure the partici-
pants felt was required from the intervention. There was
agreement across both workshops that the information
provided needed to be personalised to the individual
patient’s current situation and treatment regime. Existing
approaches, such as medication information leaflets,
were reported to give generic information on infections
and treatments that participants felt could be over-
whelming and confusing. Participants reported the need
to ensure that the quantity and complexity of information
provided was at a level that could be understood by the
majority of individuals. To address this, the workshops
decided that a summary of key points to take away should
be presented with links to reputable information sources
for patients to seek further information if required.
“Summarise it and then if you want more information
you can always go on the internet” (Female 2,
workshop 2)
“Rather than it being ‘here’s all the information in one
go’, more of the ‘you have had a positive bacteria
reading on your test, click here to read more about it’.
And then if you don’t want to [don’t] click there”
(Female 3, workshop 2)
Furthermore, the groups focused on providing practical
information that they felt was commonly missed during
discussions with healthcare professionals regarding their
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medications in hospital. This included items such as
whether it is safe to drink alcohol or drive whilst taking
certain antibiotics.
“When I had an infection and they said don’t take it if
you have reflux – that stuff I need to know. But stuff
like the massive long name of what the drug is really
called and stuff like that…. It is irrelevant to me. I just
want to know, is it going to make me sick? Can I
drive? Can I work with it…” (Male 4, workshop 1)
Participants reported that this this information needed
to be provided in a health literate format that considered
the literacy and language needs of the population who
would be utilising this intervention.
“Yes English as a second language and dyslexia is
really common.” (Female 4, workshop 1)
“[It needs to be] easy to understand, easy to just [look
down it]. Whereas here, I would look at this and say,
well, this doesn’t, I don’t care because I can’t read this, I
have no idea what this means” (Female 5, workshop 2)
Intervention development
Figure 2 demonstrates the final template that was agreed
upon and co-designed by participants in the workshops.
The intervention was embedded in an electronic clinical
decision support system that contains several different
modules linked to a central server. Although embedded
with physician-facing decision support modules, this
intervention currently sits independently of these. This
allows individual patient information to be automatically
extracted from a number of databases within the hospital.
Moreover, the clinician can also input their impression
and findings based on the clinical examination. To ensure
Table 1 Key themes identified during workshops for the development of a patient engagement intervention for promoting
enhanced communication and information provision surrounding infection management in secondary care
Category Summary of workshops decision on content Summary of workshops decision on structure
Platform Needed to be flexible, to allow use on devices, paper, in and
out of hospital, and by all age groups
The platform should also be personalisable, to allow the
patient and doctor to select relevant information depending
on the patient’s wishes
A PDF document that can be populated, printed, emailed, or
uploaded onto an application was preferred.
Mobile applications, websites, automated text systems were
also considered but were felt not to have the same level of
flexibility.
Individualised The intervention should provide information about the
individual’s current condition and treatment.
Information provided should be in summary form.
The provision of blood test results, or probabilities was not
felt to be appropriate as it could be overwhelming and
concerning to some patients.
Health literate The information must be provided in language that the majority
of citizens can understand.
The quantity of information provide must be enough to provide
key information but not overwhelming to someone who is
unwell and in hospital.
Colours and tables were not preferred.
Participants opted for the minimum amount of presented
information.
Basic explanations of conditions with examples of medical
terminology sometimes used was felt to be helpful for
following discussions and searching for further information
after the consultation.
Sign post Detailed descriptions should not be included, but references
for reputable sources of information should be provided to
help guide those who want more information.
Links to further information on reputable websites.
Blood test results were not preferred on the leaflet.
Practical advice Advice on common or important side effects of treatments
should be included.
Practical information, such as whether it is okay to drink alcohol,
drive/operate heavy machinery, and interactions with the oral
contraceptive pill whilst taking antibiotics should be included.
Educational information to promote better understanding of the
risks of drug resistant infections could be included.
Adherence to therapy should be reinforced.
Minimal numbers of side effects were preferred. The group
decided on 3–4 key side effects would be optimal.
A short description of antimicrobial resistance and where to
find further information was included for reference.
A tool to enhance
communication
The intervention should aim to enhance communication
between patient and healthcare professionals.
It should be designed to be delivered by all types of health care
professional.
It should provide a prompt to allow the patient to consider
whether they have further questions, allowing them to pick this
up during future interactions with the healthcare professional.




Information on next appointments
Information on who to contact if you have problems or
questions on discharge
Removed from the leaflet as participants felt that it overlapped
with discharge summaries that are often provided. In this case
duplication of information at different times during hospital
stay may be unhelpful.
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that individualised information was provided in a health
literate format, a number of translations automatically
occur upon generation of the personalised information
leaflet. For example, if “pneumonia” is recorded by the
healthcare professional, it will be coded to display the
diagnosis as “chest infection”. Moreover, a number of
alternative names are provided (“pneumonia”, “lower
respiratory tract infection”) automatically below on the
PDF document. This code also triggers the inclusion of a
web address that directly links to an open access patient
information leaflet on pneumonia (patient.info). Therefore,
on generating the information leaflet through the clinical
decision support tool, the clinician is able to provide a
personalised information leaflet to the patient, which
contains details of their own infection and treatment.
Pilot study
Eighteen out of thirty (60%) patients invited consented
to participate. The 12 who declined to take part did not
provide reasons for this. In total, 15/18 (83%) of the
enrolled participants completed the study. One patient
moved hospital before they could complete the pre-
intervention questionnaire, one participant was discharged
before completion of the post-intervention questionnaire,
and one patient experienced an episode of delirium after
completion of the pre-intervention questionnaire leading
to him being withdrawn from the study.
Table 2 summarises participant characteristics from
the study. Of the 17 participants who completed our
pre-intervention questionnaire, the median (range) age
was 60 (22–85) years, the majority of participants were
male (11/17; 65%). Most patients were under the care of
medical specialties within the hospital (13/17; 76%). In
the pre-intervention questionnaire, 8/17 (47%) reported
the correct infection diagnosis and 6/17 (35%) correctly
named what antibiotics they were receiving. Participants
reported that health care professionals had spent less
than 10 min discussing their infection with them in 9/17
(53%) cases. Three out of seventeen (18%) did not report
healthcare professionals discussing their infection with
them at all and 7/17 (41%) reported that healthcare
professionals had spent longer the 10 min discussing
their infections with them. Only 5/17 (29%) reported
healthcare professionals discussing their antibiotic therapy
with them during this admission.
Of the 15 patients that completed the study, the pre-
intervention questionnaire demonstrated poor knowledge
and understanding surrounding participant infections and
antimicrobial therapy. Mean (SD) scores out of 13 were
3.2 (2.2). Following the intervention, participants post-
intervention questionnaire scores improved to 8.5 (3.3)
out of 13. Feedback on the impact of the questionnaire
was positive with participants rating its usefulness a
median (range) 5 (3–6) out of 6. Thirteen out of fifteen
(87%) participants reported that they would use the
intervention again if in hospital with an infection.
Table 3 summarises the questions participants recorded
in their pre-intervention questionnaire regarding their in-
fections and subsequent management. It also summarises
participant post-intervention written feedback, outstanding
Fig. 2 Summary of intervention development and linkage with clinical decision support system
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questions, and suggestions for further development of the
tool. Pre-intervention, participants reported requiring more
information about their infections and antibiotic therapy
than they had been given. Potential side effects were
commonly reported questions that patients had. Post-
intervention, participants reported that the intervention
was useful as it provided information that had not yet
been given to them by their treating doctor. This
included information about their infection, the antibiotics
that they were taking, and general issues around whether
it is safe to drink alcohol or drive whilst taking these
medications. Feedback provided on improvements to the
intervention by participants surrounded, giving further
information on specific aspects within the document and
also prompting more detailed discussion with the doctor
following use of this intervention.
Discussion
Within this study we have demonstrated that a patient-
centred intervention, co-designed with patients to promote
engagement with infection management in secondary care,
improved participant knowledge and understanding of
their infection in the short term. Participants responded
positively to the intervention, providing data to triangu-
late findings from previous workshops, and providing
feedback on future areas that still require development
before wider deployment and evaluation.
Within secondary care there is evidence to demonstrate
that both healthcare professionals and patients desire indi-
viduals to have a greater involvement with their medica-
tions during their in-patient stay [14]. This can help reduce
medication errors and promote improved patient reported
outcomes following hospital stay for a wide range of medi-
cations [14–16]. Given our groups previous observation of
a desire from patients for better information about
antibiotic therapy and the potential impact this may
have on attitudes and behaviours, it is likely that such
interventions could have a similar benefit as seen with
other medications [3].
This study has highlighted the lack of awareness
within our population regarding their infection and anti-
biotic therapy. Recall of infection names and antibiotic
therapy were less than 50%. Less than 30% of patients
remembered their healthcare professionals discussing
Table 2 Summary of participant characteristics and questionnaire results from the pilot evaluation of the patient-focused intervention
Characteristic Description Result
Agea Median (range) years 60 (22–85)
Gendera Male (%) 11 (65)
Reported time spent discussing infection prior to interventiona
Not discussed n = (%) 3 (18)
< 10 min n = (%) 8 (47)
10–30 min n = (%) 3 (18)
> 30 min n = (%) 3 (18)
Antibiotic therapy discussed with patient prior to interventiona
Yes pre-intervention n = (%) 5 (29)
Pre-intervention knowledge and understanding scores
Median (IQR) 3 (2–5)
Mean (SD) 3.2 (2.2)
Post-intervention knowledge and understanding scores
Median (IQR) 10 (6–11)
Mean (IQR) 8.5 (3.3)
Reported usefulness of intervention Median score
(range)
1 = Not very useful
6 = Extremely useful
5 (3–6)
Would participants use the intervention again Yes – n = (%) 13 (87)
Reported optimal time to deploy the intervention
Initiation of therapy n = (%) 5 (33)
On discharge n = (%) 2 (13)
Any time during admission n = (%) 8 (53)
Legend: All analysis was performed only on participants with both pre- and post-questionnaires (n = 15) unless otherwise stated
a n = 17 who completed pre-intervention questionnaire
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their antibiotic therapy with them. There is a paucity of
data to allow comparison of these findings with other
similar studies of in-patients in secondary care. Micallef
and colleagues, previously reported on the levels of
awareness and understanding of antibiotic resistance
and stewardship in a cohort of 1450 citizens attending
hospital out-patient clinics and pharmacies in the UK
[13]. Within this study, the authors identified broad
conceptions about the development of drug-resistant
infections and appropriate antibiotic use [13]. These
findings have also been reported in community public
awareness surveys that have demonstrated poor awareness
and understanding surrounding antibiotics and infection
management across a number of different countries [17].
We are now planning to undertake a further cross-
sectional analysis of this problem to assess the levels of
awareness of in-patients both with and without infections.
Within primary care, there is evidence supporting the
role of shared decision making for reducing inappropriate
antibiotic use [2, 18–20]. However, in secondary care
during acute infection management, the need for antibiotic
therapy is often a lot clearer, patients are more unwell, and
decisions must be made rapidly, especially in the case of
sepsis [3, 21, 22]. Therefore, when providing information
on infections in secondary care interventions may need to
adopt a different approach compared to primary care,
where there often is truly a shared approach to making a
final decision on the need for therapy. This problem has
been addressed by Edwards and colleagues, who argue that
engagement of the patient in decision making alone may
be sufficient to improve understanding and involvement in
the process overall, providing a level of ownership to the
problem, whilst not requiring the focus to be on the final
decision that is made [23]. This was supported by our
findings that participants felt more informed and engaged
with the management of their infections following the
intervention, regardless of whether they had a final say in
the decision that was made. Moreover, feedback on the
intervention was overall very positive with the majority of
participants happy to use the intervention again in future.
However, a wide variation was observed with the preferred
timing of the intervention reported by participants.
This triangulates with findings from our development
workshops, where there was variation in opinion between
participants was observed on this topic.
The main finding from the workshops in this study was
the reported focus on providing individualised information
to patients that is relevant to their own specific situation.
We were able to achieve this through the integration of
this tool with a wider electronic clinical decision support
tool, EPIC IMPOC. This allows us to utilise available
electronic patient data and clinical examination findings
recorded by the patient’s physician and provided a flexible
mechanism of generating a personalised information leaflet
for deployment at any point during the patient’s hospital
stay. Despite this module not directly influencing
physician-facing decision support modules within this
study, there is a wider need to ensure that interventions
are joined up during the development of clinical decision
support tools, which are often developed with a narrow
focus on antimicrobial selection only [7]. Validation of this
intervention will now allow it to be tested in tandem with
prescriber-focused interventions within the integrated
decision support system.
A further aspect that participants in this study valued
was ensuring that the intervention could be used by any
healthcare professional, not just physicians. The role of
healthcare professionals, such as nurses and pharmacists,
is critical in infection management and appropriate anti-
biotic use [24–28]. Therefore, any tool that is developed
must keep this in mind. Within our pilot study researchers
of two different backgrounds successfully delivered the
intervention. One was a nurse (VA) and the other a junior
physician (TMR).
Table 3 Summary of survey qualitative question responses from
participants
Questions noted by participants pre-intervention Frequency
What are the side effects of taking antibiotics? 7
Where to find further information about the diagnosis? 7
Further information about the antibiotics that I am taking 5
Further information about the bacteria causing my infection 3
How long will it take for me to feel better? 2
How can I prevent this happening again in the future? 2
Post-intervention - Why was this useful? Frequency
It gave information I haven’t of been told by the doctor 4
I didn’t know the names of the antibiotics I was taking 3
Gave information about side effects 2
It provided information about driving 2
It provided information about drinking alcohol with
antibiotics
2
Covered all of the questions that I wanted to ask the doctor 2
Gave information on the infection / bug 1
Clear and understandable information 1
A good reminder of my conversation with the doctor 1
Post-intervention - How could this be improved further? Frequency
Nothing 3
More information on side effects 2
Would be better with more communication from the
healthcare professional
1
Length of treatment 1
A place to write the concerns and questions that I have 1
Provide further information on why I shouldn’t drink on this
medication
1
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This study also had its limitations. As this was a pilot
study that aimed to evaluate the intervention and provide
feedback on further improvements before larger evalu-
ation, only a small number of participants were recruited.
To try to reduce bias of outcomes, patients were recruited
from a wide number of wards and specialties, so that one
clinical team did not heavily influence the outcome of this
study. Secondly, the pilot only took place in three West
London hospitals. Therefore, it may be difficult to general-
ise this study to wider populations. However, to address
this the development workshops recruited from a large
national database, with participants attending from many
regions in south England. Thirdly, the questionnaire only
aimed to assess short term improvement in knowledge
and understanding. It is not possible to determine from
this whether there would be any medium to long term
impact from the intervention. Furthermore, the reported
lengths of discussion with healthcare professionals about
infections and antibiotics may not have been accurate
given the subjectivity of participant reporting. However,
this was felt to be appropriate within this study given that
we were assessing the participant perceptions of infor-
mation provision and communication with healthcare
professionals. Finally, this pilot study was not powered
to demonstrate statistical significant between pre- and
post-intervention questionnaires. A larger, controlled
study is now planned to assess the short, medium, and
long-term impact of this intervention of participants
receiving antibiotics in secondary care.
Conclusion
Within our study we have observed poor baseline know-
ledge of antibiotic therapy and infection management
amongst in-patients being treated for infections. Patients
are accepting of simple, individualised information leaflets
that can be delivered during routine clinical interactions.
Such an intervention, co-designed by patients and embed-
ded within a clinical decision support system was able to
improve short term knowledge and understanding of anti-
biotic therapy and infection management within patients
included in our study. This supports the need for greater
emphasis on the development of patient-centred interven-
tions to improve engagement with infections and their
management in secondary care. Further work is required
to quantify the short, medium, and long-term impacts of
such interventions on patient knowledge, understanding,
and attitudes towards antibiotic therapy.
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